About Marcel van der Brug
Marcel van der Brug is a chief scientific officer at AcuraStem.
Experience
This experience comes from Marcel van der Brug's profile and from SEC filings. For roles taken from filings, the years are when the filings name Marcel van der Brug in the role, so the role may have started earlier or lasted longer.
AcuraStem Inc Current
Chief Scientific Officer
2024 – Present · Pasadena, CA
Develops treatments for people with ALS, frontotemporal dementia and other neurodegenerative diseases.
AL
Alleo Labs Current
Scientific Advisory Board
2024 – Present
CB
Character Biosciences Current
Co-Founder & Scientific Advisory Board
2018 – Present
LC
Lifeforce Capital
Venture Partner Advisor
2024
NE
Neuron23
Project Team Lead, VP of Genetics and Data Sciences
2022 – 2024
CH
Clover Health
Co-Founder & Chief Scientific Officer, Clover Therapeutics
2018 – 2020
EB
E-Scape Bio
Group Leader, Biology Pharmacology & Biomarkers, Sr Scientist
2017 – 2018
GE
Genentech
Group Leader, Ophthalmology Metabolism Neuroscience Inflammation (OMNI) Discovery, Scientist
2011 – 2017
TC
The Scripps Research Institute - Florida campus
Staff Scientist
2008 – 2011
NH
National Institutes of Health
Postdoctoral Research Fellow
2003 – 2008
Key Colleagues at Startups
The people Marcel van der Brug works with at each company, as listed on that company's latest Form D.
AcuraStem Inc · Form D, Jun 22, 2026
Samuel Alworth
Co-founder and CEO, director
QM
Qing Liu-Michael
Director
Paul August
Co-founder and director
Justin Ichida
Co-founder and director